Occudo Quantitative Strategies LP Syros Pharmaceuticals, Inc. Transaction History

Occudo Quantitative Strategies LP

  • $501 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$3.26 - $4.66 $12,110 - $17,311
3,715 Added 22.76%
20,038 $65,000
Q3 2021

Nov 15, 2021
BUY
$4.08 - $5.66 $66,597 - $92,388
16,323 New
16,323 $73,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.25M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email